Abstract
As we saw in the preceding pages, volume retention inevitably leads to dilatation of the heart compartments. This first becomes apparent in increases of left atrial, ventricular end diastolic diameters and volumes. Published data reveal that values in the upper range of normal are the rule (London et al. 1993) and frank dilatation very frequent (between 20% and 50% in different series). This fact alone strongly suggests inadequate volume control in a large proportion of the dialysis population. Indeed a direct relationship was found between blood volume and LVDd.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Bibliography
Amann K, Neususs R, Ritz E et al. Changes in vascular architecture, independent of blood pressure in experimental uremia. Am J Hypert. 1995; 8: 409–17.
Boltwood CM, Tei C, Wong M et al. Quantitative echocardiography of the mitral complex in dilated cardiomyopathy: the mechanism of functional mitral regurgitation. Circulation. 1983; 68: 498–508.
Bonow O, Udelson E. Left ventricular diastolic dysfuncions as a cause of congestive heart failure. Ann Intern Medicine. 1992; 117: 502–10.
Bryg JR, Gordon PR, Migdal SD. Doppler detected tricuspid, mitral or aortic regurgitation in end-stage renal disease. Am J Cardiol. 1989; 63: 750–3.
Buoncristiani U, Fagugli RM, Pinciaroli MR et al. Reversal of left ventricular hypertrophy in uremic patients treated with daily hemodialysis. In: Clinical hypertension in nephrology. Karger, Basel ed. 1996: 152–6.
Burt RK, Gupta S, Suki WN et al. Reversal of left ventricular dysfunction after trans-plantation. Annals lnt Med. 1989; 111: 635–40.
Canella G, Paoletti E, Barocci S et al. Angiotensin converting enzyme gene polymor-phism and reversibility of uremic left ventricular hypertrophy following long-term antihypertensive therapy. Kidney Int. 1998; 54: 618–26.
Cirit M, Özkahya M, Soydas C et al. Disappearance of mitral and tricuspid regurgita-tion in haemodialysis patients after ultrafiltration. Nephrol Dial Transplant. 1998; 13: 389–92.
Fernanez-Reyes MJ, Bajo MA, RobeIs P et al. Mitral annular calcification in CAPD patients with low degree of hyperparathyroidism. Nephrol Dial Transplant. 1995; 10: 2090–5.
Foley RN, Parfrey Ps, Harnett JD et al. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol. 1995; 5: 2024–31.
Golf S, Lunde P, Abrahamsen M et al. Effect of hydration state on cardiac function in patients on chronic haemodialysis. Br Heart J. 1983; 49: 183–6.
Grossman W, Jones D, McLaurin P. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest. 1975; 56: 56–64.
Harnett JD, Foley RN, Kent GM et al. Congestive heart failure in dialysis patients. Prevalence, incidence, prognosis and risk factors. Kidney Int. 1995; 47: 884–90.
Hung J, Harris PJ, Uren RF et al. Uremic cardionnyopathy effect of hemodialysis on left ventricular function. New Eng J Med. 1980; 302: 547–51.
Katz AM. Cardiomyopathy of overload. New Eng J Med. 1990; 322: 100–10.
London GM, Fabiani F. Marchais J. Uremic cardiomyopathy: an inadequate left ventricular hypertrophy. Kidney Int. 1987; 31: 973–80.
London GM, Marchais SJ, Guerin AP et al. Cardiac hypertrophy and arterial alteration in end-stage renal disease. Haemodynamic factors. Kidney Int. 1993; 43 (Suppl. 4): 42–9.
Michel P. Aortic stenosis in chronic renal failure patients treated by dialysis. Nephrol Dial Transplant. 1998;13(Suppl. 4)44–8.
Özkahya M, Ok E, Cirit M et al. Regression of left ventricular hypertrophy in haemo-dialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs. Nephrol Dial Transplant. 1998; 13: 1489–93.
Perez JE, Smith CA, Meltzer VN. Pulmonary valve insufficiency: a common cause of transient diastolic murmurs in renal failure. Ann Int Med. 1985; 103: 497–502.
Raine AEG. Acquired aortic stenosis in dialysis patients. Nephron. 1994; 68: 159–68.
Ribeiro S, Ramos A, Brandao A et al. Cardiac valve calcifications in haemodialysis patients: role of calcium—phosphate metabolism. Nephrol Dial Transplant. 1998; 13: 2037–40.
Rostand SG, Drücke TB. Parathyroid hormone, vitamin D and cardiovascular disease in renal failure. Kidney Int. 1999; 56: 383–92.
Silberberg JS, Barre PE, Prichard SS et al. Impact left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int. 1989; 36: 286–90.
Szidon JP. Pathophysiology of the congested lung. Cardiol Clin. 1989; 7: 39.
Töz H, Özerkan F, Ünsal A et al. Dilated uremic cardiomyopathy in a dialysis patient cured by persistent ultrafiltration. Am J Kidney Dis. 1998; 32: 664–8.
Wallin CB, Jacobson SH, Leksell LG. Subclinical pulmonary oedema and intermittent haemodialysis. Nephrol Dial Transplant. 1996; 11: 2269–75.
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Mees, E.J.D. (2000). Special aspects of dialysis-related heart disease. In: Cardiovascular Aspects of Dialysis Treatment. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-0973-6_8
Download citation
DOI: https://doi.org/10.1007/978-94-017-0973-6_8
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-5442-5
Online ISBN: 978-94-017-0973-6
eBook Packages: Springer Book Archive